Palbociclib with Fulvestrant or Letrozole in Endocrine-Sensitive Patients with HR-Positive/HER2-Negative Advanced Breast Cancer: A Detailed Safety Analysis of the Randomized PARSIFAL Trial - Di Cosimo, S; Perez-Garcia, J M; Bellet, M (Oncologist, 2023)